Thyroid C-mobile Tumors: In rodent experiments, semaglutide continues to be demonstrated to induce thyroid C-mobile tumors. It is unfamiliar whether this hazard relates to people, but semaglutide is contraindicated in individuals with a private or loved ones record of medullary thyroid carcinoma (MTC) or patients with Multiple Endocrine Neoplasia s